Drug intelligence / Profile preview

ASP6282 + pilocarpine

Development stage
Preclinical
Lead developer
Astellas Pharma
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

ASP6282 + pilocarpine is a combination drug consisting of ASP6282, an experimental agent, and pilocarpine, a well-established cholinergic agonist. **Pilocarpine** works as a muscarinic receptor agonist, facilitating the outflow of aqueous humor in the eye (primarily used in glaucoma and presbyopia), and stimulates exocrine gland secretion, commonly for dry mouth and Sjögren's syndrome. Its mechanism is via selective muscarinic (acetylcholine) receptor activation[2][3]. **ASP6282** is an experimental agent; although detailed public mechanistic or structural information is limited, it is presumed to be pharmacologically active in ophthalmology when combined with pilocarpine. The combination aims to address ophthalmic conditions such as presbyopia or related indications where muscarinic agonism is beneficial, potentially offering improved efficacy, safety, or pharmacodynamic properties compared to pilocarpine alone.

02

Targets

M1 (Muscarinic acetylcholine receptor M1)CHRM2 (M2)CHRM3 (M3)

Beyond the preview

Go deeper on ASP6282 + pilocarpine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASP6282 + pilocarpine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call